Potential of Small Molecule Protein Tyrosine Kinase Inhibitors as Immunomodulators and Inhibitors of the Development of Diabetes

被引:17
|
作者
Little, Peter J. [1 ,2 ,3 ]
Cohen, Neale [4 ]
Morahan, Grant [5 ]
机构
[1] BakerIDI Heart & Diabet Inst, Diabet & Cell Biol Lab, Melbourne, Vic 3004, Australia
[2] Monash Univ, Alfred Hosp, Cent & Eastern Clin Sch, Dept Med, Melbourne, Vic 3004, Australia
[3] Monash Univ, Alfred Hosp, Cent & Eastern Clin Sch, Dept Immunol, Melbourne, Vic 3004, Australia
[4] BakerIDI Heart & Diabet Inst, Clin Serv Div, Melbourne, Vic 3004, Australia
[5] Western Australian Inst Med Res, Ctr Diabet Res, Perth, WA 6000, Australia
来源
基金
英国医学研究理事会;
关键词
Type; 1; diabetes; 2; imatinib; autoimmunity; NOD mouse; ENDOPLASMIC-RETICULUM STRESS; IMATINIB-MESYLATE; INSULIN SENSITIVITY; BLOOD-GLUCOSE; RISK; CHILDREN; MICE; LIFE;
D O I
10.1100/tsw.2009.28
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
[No abstract available]
引用
收藏
页码:224 / 228
页数:5
相关论文
共 50 条
  • [31] Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer
    Lee, Chieh-Chien
    Shiao, Hui-Yi
    Wang, Wen-Chieh
    Hsieh, Hsing-Pang
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (10) : 1333 - 1348
  • [32] Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy
    Noolvi, Malleshappa N.
    Patel, Harun M.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2012, 9 (01) : 84 - 125
  • [33] Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer
    Sarwar, Fatima
    Ashhad, Samreen
    Vimal, Archana
    Vishvakarma, Reena
    MEDICAL ONCOLOGY, 2024, 41 (08)
  • [34] Small molecule inhibitors of the Fes non-receptor tyrosine kinase
    Hellwig, Sabine
    Zhang, Jianming
    Filippakopoulos, Panagis
    Salah, Eidarus
    Knapp, Stefan
    Gray, Nathanael S.
    Smithgall, Thomas E.
    CANCER RESEARCH, 2010, 70
  • [35] Emerging small-molecule inhibitors of the Bruton's tyrosine kinase (BTK): Current development
    Liu, Jiakuo
    Chen, Chengjuan
    Wang, Dongmei
    Zhang, Jie
    Zhang, Tiantai
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 217
  • [36] The Recent Medicinal Chemistry Development of Jak2 Tyrosine Kinase Small Molecule Inhibitors
    Baskin, R.
    Majumder, A.
    Sayeski, P. P.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (36) : 4551 - 4558
  • [37] The development and therapeutic potential of protein kinase inhibitors
    Cohen, P
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) : 459 - 465
  • [38] A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis
    Bibi, Yuval
    Gottlieb, Alice B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (04) : 654 - 658
  • [39] Small molecule inhibitors of the RNA-dependent protein kinase
    Jammi, NV
    Whitby, LR
    Beal, PA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (01) : 50 - 57
  • [40] Development for Anticancer Therapy: Small-Molecule Inhibitors Targeting Protein Kinase B
    Chen, Shi-feng
    Chen, Jian-Zhong
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (09) : 1272 - 1294